发明名称 Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure
摘要 An agent for reducing risk in onset of diseases ascribable to non-dipping circadian profile of blood pressure is provided. This agent is capable of effectively lowering SBP from night to early morning in individuals with non-dipping circadian profile of blood pressure, in particular, normal individuals with normal SBP and DBP among them, and is thus capable of reducing risk in onset, particularly likely in the morning, of diseases caused by circadian variation of blood pressure. The agent is intended for administration to such subjects, and contains a hydrolysate or a concentrate thereof, containing Val-Pro-Pro and Ile-Pro-Pro and obtained by hydrolysis of animal milk protein.
申请公布号 US8883731(B2) 申请公布日期 2014.11.11
申请号 US201313850610 申请日期 2013.03.26
申请人 CALPIS Co., Ltd 发明人 Takahashi Mari;Yamamoto Naoyuki;Yamada Kazuhisa;Iketani Toshirou
分类号 A61K38/06;A61K38/01 主分类号 A61K38/06
代理机构 Sughrue Mion, PLLC 代理人 Sughrue Mion, PLLC
主权项 1. A method for increasing magnitude of nocturnal or early morning decline in mean systolic blood pressure of a non-dipper individual, comprising orally administering a animal milk protein hydrolysate containing Ile-Pro-Pro tripeptide and Val-Pro-Pro tripeptide, or a concentrate thereof, to the non-dipper individual, wherein said non-dipper individual has mean systolic blood pressure (SBP) of less than 130 mmHg and mean diastolic blood pressure (DBP) of less than 80 mmHg, and shows a less than 10% decline in mean systolic blood pressure during a time period of 0:00-5:00 compared to mean systolic blood pressure during a time period of 8:00-21:00, all as measured brachially every 30 minutes with a 24-hour ambulatory blood pressure monitor.
地址 Tokyo JP
您可能感兴趣的专利